Sai Life Sciences reports 57% rise in Q4 consolidated net profit

14 May 2025 Evaluate

Sai Life Sciences has reported results for fourth quarter (Q4) and year ended March 31, 2025.

The company has reported 46.24% rise in its net profit at Rs 89.94 crore for the quarter under review as compared to Rs 61.50 crore for the same quarter in the previous year. The total income of the company increased by 33.61% at Rs 576.83 crore for Q4FY25 as compared Rs 431.73 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 57.26% rise in its net profit at Rs 88.27 crore for fourth quarter ended March 31, 2025 as compared to Rs 56.13 crore for the same quarter in the previous year. The total income of the company increased by 33.12% at Rs 589.11 crore for Q4FY25 as compared Rs 442.55 crore for the corresponding quarter previous year.

For the year ended March 31, 2025, the company has reported 82.15% rise in its net profit at Rs 173.46 crore as compared to Rs 95.23 crore for the previous year. The total income of the company increased by 15.98% at Rs 1,679.38 crore for year under review as compared to Rs 1,448.01 crore for year ended March 31, 2024.

For the year ended March 31, 2025, on the consolidated basis, the company has reported over two folds jump in its net profit at Rs 170.13 crore as compared to Rs 82.81 crore for the previous year. The total income of the company increased by 15.87% at Rs 1,731.35 crore for year under review as compared to Rs 1,494.27 crore for year ended March 31, 2024.

Sai Life Sciences Share Price

896.20 -9.90 (-1.09%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×